Hao Liu

5.6k total citations
167 papers, 4.0k citations indexed

About

Hao Liu is a scholar working on Molecular Biology, Cancer Research and Oncology. According to data from OpenAlex, Hao Liu has authored 167 papers receiving a total of 4.0k indexed citations (citations by other indexed papers that have themselves been cited), including 97 papers in Molecular Biology, 46 papers in Cancer Research and 42 papers in Oncology. Recurrent topics in Hao Liu's work include MicroRNA in disease regulation (30 papers), Bone Metabolism and Diseases (20 papers) and Epigenetics and DNA Methylation (15 papers). Hao Liu is often cited by papers focused on MicroRNA in disease regulation (30 papers), Bone Metabolism and Diseases (20 papers) and Epigenetics and DNA Methylation (15 papers). Hao Liu collaborates with scholars based in China, United States and Australia. Hao Liu's co-authors include Yunsong Liu, Yongsheng Zhou, Longwei Lv, Ranli Gu, Yongsheng Zhou, Adam I. Riker, Ming Zhou, Jianrong Lu, Guiyuan Li and Yan Ding and has published in prestigious journals such as Journal of Biological Chemistry, SHILAP Revista de lepidopterología and Nano Letters.

In The Last Decade

Hao Liu

160 papers receiving 4.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Hao Liu China 37 2.3k 1.1k 854 550 418 167 4.0k
Hong Li China 36 2.4k 1.1× 1.0k 1.0× 827 1.0× 391 0.7× 390 0.9× 159 4.4k
Rui Xie China 39 2.3k 1.0× 1.0k 0.9× 704 0.8× 1.0k 1.9× 582 1.4× 146 4.9k
Chrysostomi Gialeli Greece 20 1.9k 0.8× 1.0k 0.9× 1.0k 1.2× 666 1.2× 396 0.9× 35 4.4k
Kai‐Tai Yao China 35 2.0k 0.9× 1.0k 0.9× 966 1.1× 518 0.9× 291 0.7× 121 3.9k
Andreas Evdokiou Australia 40 2.1k 0.9× 563 0.5× 1.4k 1.7× 488 0.9× 576 1.4× 100 4.2k
Hui Lin China 33 2.0k 0.9× 1.1k 1.0× 513 0.6× 884 1.6× 291 0.7× 141 3.9k
Jie Ding China 42 2.9k 1.3× 1.3k 1.1× 579 0.7× 315 0.6× 367 0.9× 189 5.6k
Qunzhou Zhang United States 36 1.6k 0.7× 832 0.8× 894 1.0× 331 0.6× 397 0.9× 52 4.2k
Li Sun China 41 2.6k 1.1× 1.3k 1.2× 562 0.7× 295 0.5× 637 1.5× 153 4.8k
Chun-Chi Liang United States 15 2.0k 0.9× 554 0.5× 596 0.7× 471 0.9× 316 0.8× 17 4.6k

Countries citing papers authored by Hao Liu

Since Specialization
Citations

This map shows the geographic impact of Hao Liu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hao Liu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hao Liu more than expected).

Fields of papers citing papers by Hao Liu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hao Liu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hao Liu. The network helps show where Hao Liu may publish in the future.

Co-authorship network of co-authors of Hao Liu

This figure shows the co-authorship network connecting the top 25 collaborators of Hao Liu. A scholar is included among the top collaborators of Hao Liu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hao Liu. Hao Liu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zhu, Yuan, Yanan Ding, Ranli Gu, et al.. (2025). Apoptotic vesicles inhibit bone marrow adiposity via wnt/β-catenin signaling. Regenerative Therapy. 29. 262–270. 1 indexed citations
2.
Sun, Mengyao, Yun Gu, Jieti Wang, et al.. (2025). Smad4 loss identifies aggressive subtype with immunotherapy and anti-HER-2 treatment resistance in gastric cancer. British Journal of Cancer. 132(12). 1148–1157.
4.
Li, Tao, et al.. (2024). Cancer stem cell specificity as new targets in breast tumor treatment. Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics. 33(4). 811–819. 1 indexed citations
5.
Zhu, Yuan, Ranli Gu, Xuenan Liu, et al.. (2023). Apoptotic Vesicles Regulate Bone Metabolism via the miR1324/SNX14/SMAD1/5 Signaling Axis. Small. 19(16). e2205813–e2205813. 22 indexed citations
6.
Li, Qian, et al.. (2023). Anti-inflammatory and antioxidant traditional Chinese Medicine in treatment and prevention of osteoporosis. Frontiers in Pharmacology. 14. 1203767–1203767. 29 indexed citations
7.
Dai, Wei, Hong Yu, Chen Zhang, et al.. (2023). Combined linkage mapping and association analysis uncovers candidate genes for 25 leaf-related traits across three environments in maize. Theoretical and Applied Genetics. 136(1). 6 indexed citations
8.
Gu, Ranli, Hao Liu, Menglong Hu, et al.. (2023). D-Mannose prevents bone loss under weightlessness. Journal of Translational Medicine. 21(1). 8–8. 10 indexed citations
9.
Zhang, Xiang, Yi Yang, Yiwei Shen, et al.. (2022). SeUneter: Channel attentive U-Net for instance segmentation of the cervical spine MRI medical image. Frontiers in Physiology. 13. 1081441–1081441. 10 indexed citations
10.
Liu, Hao, Tianlei Xu, Ying Cheng, et al.. (2019). Altered 5-Hydroxymethylcytosine Landscape in Primary Gastric Adenocarcinoma. DNA and Cell Biology. 38(12). 1460–1469. 6 indexed citations
11.
Liu, Xuenan, Zheng Li, Hao Liu, et al.. (2019). Low concentration flufenamic acid enhances osteogenic differentiation of mesenchymal stem cells and suppresses bone loss by inhibition of the NF-κB signaling pathway. Stem Cell Research & Therapy. 10(1). 213–213. 19 indexed citations
13.
Deng, Min, Ruixin Zhang, Qinwei Qiu, et al.. (2017). TET-Mediated Sequestration of miR-26 Drives EZH2 Expression and Gastric Carcinogenesis. Cancer Research. 77(22). 6069–6082. 42 indexed citations
14.
Chen, Qiang, Guimiao Lin, Nan Wu, et al.. (2016). Early exposure of rotating magnetic fields promotes central nervous regeneration in planarian Girardia sinensis. Bioelectromagnetics. 37(4). 244–255. 17 indexed citations
15.
Ge, Yu‐Zheng, Luwei Xu, Zheng Xu, et al.. (2015). Expression Profiles and Clinical Significance of MicroRNAs in Papillary Renal Cell Carcinoma. Medicine. 94(16). e767–e767. 22 indexed citations
16.
Li, Yang, Hao Liu, Yingying Huang, et al.. (2013). [Effects of cisplatin combined with heparanase inhibitor on proliferation and invasion of human nasopharyngeal carcinoma cells].. PubMed. 48(4). 609–14. 1 indexed citations
17.
Zhou, Ming, Zixing Liu, Yuhua Zhao, et al.. (2010). MicroRNA-125b Confers the Resistance of Breast Cancer Cells to Paclitaxel through Suppression of Pro-apoptotic Bcl-2 Antagonist Killer 1 (Bak1) Expression. Journal of Biological Chemistry. 285(28). 21496–21507. 347 indexed citations
18.
Jiang, Guohong, Jing Li, Zhuo Wang, et al.. (2010). [Applying a "stage of behaviors change" model on nutrition intervention in farmers].. PubMed. 39(6). 719–22. 5 indexed citations
19.
Wen, Yu, Sarah F. Giardina, Manny D. Bacolod, et al.. (2006). GROα Is Highly Expressed in Adenocarcinoma of the Colon and Down-Regulates Fibulin-1. Clinical Cancer Research. 12(20). 5951–5959. 53 indexed citations
20.
Wilkinson, Hilary, Johanna Dahllund, Hao Liu, et al.. (2002). Identification and Characterization of a Functionally Distinct Form of Human Estrogen Receptor β. Endocrinology. 143(4). 1558–1558. 27 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026